The U.S. SEC has received amended filings for the INJ ETF, stating that the ETF application process for $INJ is still moving forward and has not been put on hold. For Layer-1 blockchain projects like Injective that focus on financial use cases, the key point is not the mere act of “receiving documents,” but whether the SEC will continue to issue inquiries, open the comment period, and advance into a more substantive review phase.
Submitting amended materials is a common step in regulatory communication. It does not mean approval has been granted, nor does it imply that funds will enter immediately. Short-term sentiment may be catalyzed by the news, but the question of whether the momentum will last still depends on the progress of the Injective ecosystem, developer activity, trading volumes, and overall market risk appetite.
If the ETF achieves a substantive breakthrough in the future, it could help improve traditional investors’ perception of Injective; however, before results are finalized, repeated fluctuations and price volatility are difficult to avoid. It’s advisable to manage position size and avoid chasing rallies.
#INJ #Injective #ETF
Submitting amended materials is a common step in regulatory communication. It does not mean approval has been granted, nor does it imply that funds will enter immediately. Short-term sentiment may be catalyzed by the news, but the question of whether the momentum will last still depends on the progress of the Injective ecosystem, developer activity, trading volumes, and overall market risk appetite.
If the ETF achieves a substantive breakthrough in the future, it could help improve traditional investors’ perception of Injective; however, before results are finalized, repeated fluctuations and price volatility are difficult to avoid. It’s advisable to manage position size and avoid chasing rallies.
#INJ #Injective #ETF